< Back | |
07 Apr 2014 | |
Sun Pharmaceutical Industries Ltd has informed BSE that the Board of Directors of the Company at its Meeting held on April 06, 2014 has approved the scheme of arrangement between Ranbaxy Laboratories Limited and the Company under the provisions of the sections 391 to 394 and other applicable provisions of the Companies Act, 1956 and corresponding provisions of the Companies Act, 2013 subject to receipt of necessary approvals, consents and filings.<br/><br/>The Board of Directors has recommended the share exchange ratio of 8 fully paid up equity shares of Rs. 1/-each of the Company for every 10 equity shares of Rs. 5/- each of Ranbaxy Laboratories Limited. | |
View all announcements for SUN PHARMACEUTICAL INDUSTRIES LTD. | Source: BSE India |